About this episode
Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line results from REDEFINE which studied the new drug CagriSema.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Docs Who Lift publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Docs Who Lift
Does Metabolically Healthy Obesity Even Exist?
Docs Who Lift
Aug 30, 202648:28pending
Is Your Obesity Genetic? Food Noise and Bardet-Biedl Syndrome Explained
Docs Who Lift
Aug 3, 202639:46pending
PCOS Renamed to PMOS? Here's Why and What Changes for You
Docs Who Lift
Jul 7, 202636:52pending
Are Peptides the New Snake Oil? What the Actual Science Says With Barbell Medici...
Docs Who Lift
Jun 17, 202657:24pending